Presentation Information
[3P-877]Development of Therapeutic Strategies Targeting Metabolic Reprogramming Associated with Acquired Drug Resistance in EGFR-Mutant Lung Cancer
○Wataru Nakajima1, Ishino KousukKousuke1,2, Yumi Asano1, Ryuji Ohashi2, Hayashi Yamamoto1 (1. Dept. Mol. Oncl., Inst. Adv. Med. Sci., Nippon Med. Sch. , 2. Dept. Path., Nippon Med. Sch.)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in